作者：
Brittany L,Bychkovsky [1]
;
Mayra E,Ferreyra [2]
;
Kathrin,Strasser-Weippl [3]
;
Christina I,Herold [4]
;
Gilberto,de Lima Lopes [1]
;
Don S,Dizon [2]
;
Kathleen M,Schmeler [5]
;
Marcela,Del Carmen [6]
;
Tom C,Randall [7]
;
Angelica,Nogueira-Rodrigues [8]
;
Aknar Freire,de Carvalho Calabrich [9]
;
Jessica,St Louis [10]
;
Caroline M,Vail [11]
;
Paul E,Goss [12]
作者单位：
Department of Breast Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[1]
Harvard Medical School, Boston, Massachusetts.
[2]
Oncology Department, Maria Curie Hospital, Buenos Aires, Argentina.
[3]
Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria.
[4]
Clinical Oncology, Cancer Institute of Sao Paulo State, Sao Paulo, Brazil.
[5]
Johns Hopkins University School of Medicine, Baltimore, Maryland.
[6]
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
[7]
The University of Texas MD Anderson Cancer Center, Houston, Texas.
[8]
Division of Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
[9]
Global Oncology Initiative, Dana-Farber Harvard Cancer Center, Boston, Massachusetts.
[10]
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
[11]
Brazilian Gynecologic Oncology Group, Federal University, Minas Gerais, Brazil.
[12]
Clinica AMO, Salvador, Bahia, Brazil.
[13]
The Global Cancer Institute, Boston, Massachusetts.
[14]
Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, Massachusetts.
[15]
University of New England, Biddeford, Maine.
[16]
DOI
10.1002/cncr.29813
PMID
26670695
发布时间
2022-03-10
换一批
换一批
